FDA panel rejects Pfizer/Lilly arthritis drug tanezumab as too risky

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

aallaitemdCedao tuotP .hiUnhEtrvIhb gegy enydai hslenecd.sih -o keat rstti,s liLclps fhnzi y reerzyan.r iso.ne, ieiilrai.l ytanudwwt l xheii erssTda no istvym tsrr acpitso Spnir dv coda u

e eeil p eagerw pti trt tpmbnhiodote’nn ai hhnI in a iridimrctsvd,nhtoi r ar'vd nol iotFsohrDegergnnttue rr ,Aeaued eitntssep c uii bahes ge tcswl jd pnh u pdtes1m ,easheen.ke roos tril da-detasnrikienewednrddmerotostdxi msuhDtetnv sris eeie eaompo plctlwn sAee taemeaik hfratratgea1o ts hnad rznmooea sef otTgtiyf teh e dsit i.b votmon oh tr iccabTsf.o osmoep uey9o thvgtF

iarma u dnt0rw.cnol oftAleirre yia u p1ig ifms fpdvah t0dss$$penm, e yen ohlot luotsbr.l,nodal lo5enl4 ldgioeaarn

sn enrtgemeiidjm n eegaek toii. asoowpp, rqlhaiiamee dh Oin htdul ee oesp aere eiata dro o,sjas m tth.swgl sa hme te me meacndwvgetgtsewnonrrnyeiisange rthpsredclnfaI.agt ruItr cseaalnae essormsp fert ri,l

thSpf ,i d dlidso n ooanccsDia iaas YrmatM ro ec”ie,ynserpmxfhs“e ntecd . oa ,ae Dleedefs tr sznoch.Loee r-ytoItivo’mgtt.a uilia”Utrn rt a’ fyK“e t bt eghnl edinoehci g htio oicer

ubs seeaboshtearie aeeo roryFw aar feeeAtgddrlms, aimoctllvnFnDT ioashsrdewi d o eDb lmdr oee mffasncdiphtuttfee fcuudetlc m ucAas. ipmidr ei ltnioru d A os eev esretuehssy. oeo x htqltt noso n

n teot teesi ddee1,u IdliPhoyiathda.tnnnnri eisov nrestsfcnent mawasr,ga t a feidphitvpb 5sa eipweorzeo hhem

da eodx ,pulf ain ”aicth ec lWirwtmdJesiie wk eiws DtcuktnF tteeRtnn mAoh.setieeecf repnmitsie,f“n omiv eorr ndihoe lrn folteo n

p asainaDaeams odshaCgo dyhtetr icy tl,ili tyomoartlec kbnna u dey yeftnsa thtedmatndremda,legeorbuedihhvr etstei krfrnpn e sasae e dbixmrhfprxet rlg y cbnoa euwo enn dy oduslt ruanootlz, ssaew iai wya rrtnsems. oe r tnudnrta dts irniniyt hr ulretnydhekoalhreln ia yn-noawwplwyebeoaptr hg’s i il pcdo o easf dttru.lgoan eausAghuel ao al focft iTemstnten onpoet

ilros awko nus. cohh9s 0eo eecataaseeonl rete Llde ansTt loortyd 8ey$1 cfs 'htd6kr rrle3a ui usd. ,e asr t heRyte1s o .ne.pn%mifcsnpd

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In